|

N-Acetyl cysteine Clinical Trials

3 actively recruiting trials across 1 location

Also known as: NAC

Pipeline

Phase 2: 1Phase 3: 1Phase 4: 1

Top Sponsors

  • Emmanuelle Waubant, MD PhD1
  • Emily Krauss1
  • Cairo University1

Indications

  • Cancer2
  • Multiple Sclerosis, Secondary Progressive1
  • Multiple Sclerosis, Primary Progressive1
  • Carpal Tunnel Release1
  • Carpal Tunnel1

Other2 trials

The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome
Phase 4
The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients
Phase 3

San Francisco, California1 trial

Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

University of California, San Francisco

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.